Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

NCT03428646 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

858

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: Dupilumab

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]